Pfizer: names former FDA head on board
(CercleFinance.com) - Pfizer said that it has appointed former US Food and Drug Administration (FDA) head Scott Gottlieb to its board of directors, effective immediately.
A physician and medical policy expert, Gottlieb, age 47, served as commissioner of FDA from 2017 to 2019.
"We are fortunate to have Dr. Gottlieb join Pfizer's board of directors," said Ian Read, Pfizer's executive chairman. "Scott's expertise in health care, public policy and the industry will be an asset to our company," he added.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
A physician and medical policy expert, Gottlieb, age 47, served as commissioner of FDA from 2017 to 2019.
"We are fortunate to have Dr. Gottlieb join Pfizer's board of directors," said Ian Read, Pfizer's executive chairman. "Scott's expertise in health care, public policy and the industry will be an asset to our company," he added.
Copyright (c) 2019 CercleFinance.com. All rights reserved.